BAPTIST HEALTH HARDIN
1. Target Overview & Investment Thesis
BAPTIST HEALTH HARDIN is a 259-bed suburban community hospital in HARDIN, KY with $459.5M in net patient revenue and a -1.5% operating margin. The hospital serves a payer mix of 29.7% Medicare, 0.7% Medicaid, and 69.6% commercial.
Thesis: Undervalued. Our ML models identify $33.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.5% to 5.9% (+736bps).
| Net Revenue HCRIS | $459.5M |
| Current EBITDA COMPUTED | $-6.7M |
| Operating Margin COMPUTED | -1.5% |
| Occupancy HCRIS | 57.4% |
| Revenue / Bed COMPUTED | $1.8M |
| Net-to-Gross HCRIS | 16.0% |
| Distress Probability ML | 43.8% |
2. Market Context & Competitive Position
KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -1.5% places it below the state median. Among 22 size-comparable peers (130-518 beds), the median margin is -3.1%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (130-518), prioritizing same-state peers. 22 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BAPTIST HEALTH HARDIN (Target) | KY | 259 | $459.5M | -1.5% |
| ST ELIZABETH HEALTHCARE | KY | 448 | $1.07B | -13.2% |
| UNIVERSITY OF LOUISVILLE HOSPI | KY | 333 | $806.1M | -6.9% |
| BAPTIST HEALTH LEXINGTON | KY | 434 | $760.6M | 2.8% |
| OWENSBORO HEALTH REGIONAL HOSP | KY | 302 | $678.6M | 11.1% |
| BAPTIST HEALTH LOUISVILLE | KY | 454 | $677.1M | -7.2% |
| PIKEVILLE MEDICAL CENTER | KY | 328 | $555.1M | -16.6% |
| KINGS DAUGHTERS MEDICAL CENTER | KY | 367 | $542.4M | -20.5% |
| THE MEDICAL CENTER | KY | 310 | $451.0M | 4.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $33.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $9.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $9.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $9.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $5.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $294K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-6.7M |
| + RCM Uplift | +$33.8M |
| Pro Forma EBITDA | $27.1M |
| Current Margin | -1.5% |
| Pro Forma Margin | 5.9% |
| WC Released (1x) | $17.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-10.4M | $293.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-10.4M | $319.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-9.3M | $428.0M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-9.3M | $464.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-11.4M | $128.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-11.4M | $137.1M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 22 hospitals with 130-518 beds
- Same-state prioritization (n=23)
- Comp margins: P25=-15.9% / P50=-3.1% / P75=3.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.